SVG105

N/A

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameSVG105
Drug Alias NameSVG105SVG-105
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsMalformations of Cortical DevelopmentTuberous Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSoVarGen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAngelini PharmaSoVarGen Co Ltd
Inactive CompaniesN/A
Active IndicationsMalformations of Cortical DevelopmentTuberous Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A